{"filing":{"accession_number":"0001628280-26-041651","cik":"0001770787","ticker":"TXG","company_name":"10x Genomics, Inc.","form":"8-K","filing_date":"2026-06-08","report_date":null,"primary_document":"txg-20260604.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1770787/000162828026041651/txg-20260604.htm"},"events":[{"id":6349,"run_id":5562,"accession_number":"0001628280-26-041651","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 filing discloses the final voting results from 10x Genomics' annual meeting of stockholders held on June 4, 2026, covering three proposals: election of three Class I directors (Serge Saxonov, Benjamin J. Hindson, and John R. Stuelpnagel), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure includes vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.","company_name":"10x Genomics, Inc.","ticker":"TXG","filing_date":"2026-06-08","form":"8-K","submitted_at":null,"items":[{"id":5296,"accession_number":"0001628280-26-041651","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the final voting results from 10x Genomics' annual meeting of stockholders held on June 4, 2026, covering three proposals: election of three Class I directors (Serge Saxonov, Benjamin J. Hindson, and John R. Stuelpnagel), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure includes vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:48:06.416009+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5296,"accession_number":"0001628280-26-041651","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the final voting results from 10x Genomics' annual meeting of stockholders held on June 4, 2026, covering three proposals: election of three Class I directors (Serge Saxonov, Benjamin J. Hindson, and John R. Stuelpnagel), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure includes vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:48:06.416009+00:00","company_name":"10x Genomics, Inc.","ticker":"TXG","filing_date":"2026-06-08"}]}